We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Boyds Acquires New Cambridge Office to Support Rapid Growth

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
Boyds, the drug development consultancy which helps pharmaceutical companies translate great science into marketable medicines for patient benefit, has relocated into new premises in Cambridge.

The company has invested in excess of £0.5m in the purchase and complete refurbishment of a 1700 sq ft building located at South Cambridge Business Park in Sawston.

Boyds was previously located in Cottenham, a village on the outskirts of the city, and its head office will remain in Crewe, Cheshire.

Professor Alan Boyd, CEO and founder of Boyds said the team had outgrown its former property after a period of swift growth.

He said: “Our team has grown significantly in the last 12 months and we needed more space so we could futureproof our building for further new capacity in the months and years ahead.

“We remain in a prime location, close to academic groups, start-up hubs and industry, with several science parks within a five-mile radius.

“We also now have a dedicated meeting room facility that can support large client meetings and seminars.”

Professor Boyd said Boyds was committed to Cambridge as the city continues to be a thriving scientific hub that is recognised globally for its excellence in innovative research, and can be easily reached from London.

He added: “Cambridge is an ideal location for Boyds as it is optimally aligned with our goal to provide expert consultancy services for clients globally who are focusing on innovative products and treatment approaches.”